Glucose and Motivation States

November 19, 2025 updated by: University of South Florida

Impact of Blood Glucose on Motivation States: A Double-Blind Placebo-Controlled Study

The purpose of this study is to evaluate how motivation is impacted by exercise and beverage consumption. You will be asked to report to our lab for 5 visits each separated by 2+ days over a period of 2-3 weeks.

Study Overview

Study Type

Interventional

Enrollment (Estimated)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • Florida
      • Tampa, Florida, United States, 33620
        • Recruiting
        • University of South Florida
        • Contact:
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Body mass index 18-30 m/kg^2
  • Health Status: generally healthy; no cardiopulmonary/metabolic/orthopedic disease or limitations
  • Blood Pressure: excluded with SBP of 130+ mmHg or DBP of 80+ mmHg
  • Glucose Status: excluded and instructed to seek medical consultation if fasting values are <70 mg/dl or >125 mg/dl; included but encouraged to seek medical consultation if fasting values are 100-125 mg/dl

Exclusion Criteria:

  • None

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Exercise + sugar drink
Exercise 30 minutes at moderate intensity (10% below ventilatory threshold)
Consume 250mL beverage (water + 6 tablespoons table sugar)
Placebo Comparator: Exercise + non-sugar drink
Exercise 30 minutes at moderate intensity (10% below ventilatory threshold)
Consume 250mL beverage (water + 1.5 teaspoons of stevia powder)
Active Comparator: Rest + sugar drink
Consume 250mL beverage (water + 6 tablespoons table sugar)
Placebo Comparator: Rest + non-sugar drink
Consume 250mL beverage (water + 1.5 teaspoons of stevia powder)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
State Motivation to Move
Time Frame: 60 minutes
Score on movement subscale of Cravings for Rest and Volitional Energy Expenditure Survey (0 is lowest, 100 is highest)
60 minutes

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
State motivation to rest
Time Frame: 60 minutes
Score on rest subscale of Cravings for Rest and Volitional Energy Expenditure Survey (0 is lowest, 100 is highest)
60 minutes

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 30, 2025

Primary Completion (Estimated)

August 1, 2026

Study Completion (Estimated)

August 1, 2026

Study Registration Dates

First Submitted

November 19, 2025

First Submitted That Met QC Criteria

November 19, 2025

First Posted (Actual)

November 28, 2025

Study Record Updates

Last Update Posted (Actual)

November 28, 2025

Last Update Submitted That Met QC Criteria

November 19, 2025

Last Verified

November 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

Individual deidentified participant data (including data dictionaries) will be shared. This includes individual participant data that underlie the results reported in any aspect of a published article (text, tables, figures, and appendices).

Other documents that will be available include the study protocol, statistical analysis plan, informed consent form, and analytic code. The data will be available immediately after publication with no end date. Data will be shared with researchers who provide a methodologically sound proposal to achieve aims in the approved proposal. Proposals should be directed to Dr. Garrett Ash at Yale University (garrett.ash@yale.edu). To gain access, data requesters will need to sign a data access agreement.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Motivation

Clinical Trials on Exercise

Subscribe